As officials struggle to fight the opioid epidemic that is plaguing the country, some big cities are considering creating "safe injection" sites. Addicts would be able to use their drugs under the watch of medical professionals, and they would be provided clean needles. While no city has submitted a formal plan, the idea is already stirring up controversy.
Dina Fine Maron, Health & Medicine Editor at Scientific American, explains the science behind safe injection sites. Allowing addicts to use drugs under supervision and with clean needles helps to reduce diseases associated with intravenous drug use such as HIV.
While no city in the United States has a "safe injection" site, Fine Maron says existing sites in Europe and Canada have proven to be a success. Data shows that opening these sites helps reduce opioid-related deaths and problems.
Mark Kaufman, science reporter at Mashable, discusses President Trump's surprising pick to lead the White House Office of Science and Technology Policy, atmospheric scientist Kelvin Droegemeier.
These are the headlines you Need2Know for Thursday.
The electric automaker said most factories would hit a run rate of 10,000 of the mass-market vehicles a week by the end of the year, suggesting the company could be on the path to achieving profitability. The company did still report a wider loss than expected for the current quarter, but it said it burned through less cash than in the first quarter.
These are the headlines you Need2Know.
These are the headlines you Need2Know.
Narcan, the nasal spray that saved Demi Lovato from overdosing, is now available without a prescription in 49 states. Roger Crystal, MD, CEO of Opiant Pharmaceuticals and founder of the drug, was interviewed Thursday by Cheddar.
These are the headlines you Need2Know.
These are the headlines you Need2Know.
A recent survey by research firm Cohn & Wolfe found that 86 percent of Americans think companies should be socially and environmentally responsible. Burt's Bees is carbon-neutral certified and hasn't sent any waste to a landfill since 2010. Paula Alexander, Director of Sustainable Business at the company, tells Cheddar why it's important to work for a company that makes a difference.
Peter Loftus, Reporter at the Wall Street Journal, is skeptical of pharmaceutical companies touting lower drug prices. Merck may be cutting prices on medications, Loftus told Cheddar, but the ones affected represent a smaller percentage of the company's total sales.
